Altimmune ALT
NASDAQ ALT
$1.93 -0.01 (-0.52%)
At close: Nov 11, 2026 · 4:00 PM EST

Altimmune (ALT) Return on Sales [ROS] (2009 - 2025)

Updated

Altimmune's Return on Sales [ROS] was -111126.92% in Q4 2025, up 386193.08 percentage points from -497320.00% a year earlier and up 306053.08 percentage points from the prior quarter.

Analysis

Altimmune (ALT) Return on Sales [ROS] (2009 - 2025) Analysis & Trends

For FY2025, Return on Sales [ROS] at Altimmune came in at -230460.98%, up 285399.02 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of -229791.48 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -515860.00% in FY2024 (-493341.46 pp), -22518.54% in FY2023 (+106510.87 pp), -129029.41% in FY2022 (-126831.82 pp) and -2197.60% in FY2021 (-1528.10 pp).
  • The Q4 2025 figure marks the highest quarterly Return on Sales [ROS] since Q4 2023.
  • Compared with a year earlier, Return on Sales [ROS] has increased for four straight quarters, with an average year-over-year change of -115277.06 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q3 2023 (a gain of 1231373.48 percentage points); the worst was Q3 2022 (a drop of 1216584.81 percentage points).
  • Per Business Quant data, ALT's Return on Sales [ROS] in the three quarters before Q4 2025 was -417180.00% (Q3 2025), -458440.00% (Q2 2025) and -436300.00% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Altimmune 377.28 Mn -764.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -111,126.92%
Sep 30, 2025 -417,180.00%
Jun 30, 2025 -458,440.00%
Mar 31, 2025 -436,300.00%
Dec 31, 2024 -497,320.00%
Sep 30, 2024 -495,340.00%
Jun 30, 2024 -534,900.00%
Mar 31, 2024 -535,880.00%
Dec 31, 2023 -90,872.97%
Sep 30, 2023 -6,226.52%
Jun 30, 2023 -300,116.67%
Mar 31, 2023 -103,614.29%
Dec 31, 2022 -88,823.08%
Sep 30, 2022 -1,237,600.00%
Jun 30, 2022 -254,937.50%
Mar 31, 2022 -60,934.38%
Dec 31, 2021 -731.92%
Sep 30, 2021 -21,015.19%
Jun 30, 2021 -18,148.91%
Mar 31, 2021 -1,773.39%
API Access

Altimmune Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ALT&period=max&api_key=YOUR_API_KEY